This initiative aims to strengthen domestic pharmaceutical production, improve supply chain control, and accelerate innovation through advanced technologies like artificial intelligence and machine learning.
USA — Bristol Myers Squibb, a prominent pharmaceutical company, has recalibrated its sales expectations for its newer medicines, signaling a more gradual revenue growth trajectory…
USA — Bristol Myers Squibb has entered into an agreement to acquire Mirati Therapeutics for US$4.8 billion, in a move aimed at solidifying its position…
USA — Pharmaceutical company Bristol-Myers Squibb (BMS) has once again expanded its collaboration with Evotec, a drug discovery and development company. BMS has paid another…
GERMANY — Bristol Myers Squibb, following its European approval last September, has announced that it will not be launching Opdualag, an infusion of Opdivo and…
UNITED KINGDOM – Bristol Myers Squibb has acquired Turning Point Therapeutics in a US$4.1 billion deal and a new cancer asset slated to hit the…